• Pharma
  • May 15, 2018
  • 191 views
Orchid Pharma faces liquidation as lenders reject resolution plan

MUMBAI: The lenders to Orchid Pharma have rejected the resolution plan of the bankrupt company, a decision that could push the troubled drug-maker toward liquidation. “The resolution professional has conducted…

  • Pharma
  • May 14, 2018
  • 176 views
USFDA completes inspection of Lupin’s Nagpur plant

New Delhi: Pharma major Lupin today said the US health regulator has completed inspection of its Nagpur facility without making any observations. In a BSE filing, Lupin “announced successful completion…

  • Pharma
  • May 11, 2018
  • 221 views
ASSOCHAM urges greater utilisation of technology in pharmaceuticals

New Delhi: Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical sector, a top Union Health Ministry official said at an…

  • Pharma
  • May 9, 2018
  • 160 views
Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018. The company had…

  • Pharma
  • May 4, 2018
  • 208 views
CDSCO issues show cause notice to Glenmark over clinical trial in Jaipur

The clinical trial of Glenmark Pharma’s osteoarthritis pain medication at a hospital in Jaipur has been flagged by the Central Drugs Standard Control Organisation (CDSCO) over violations like falsification of…

  • Pharma
  • May 3, 2018
  • 177 views
Ajanta Pharma Q4 PAT down 17% at Rs 94 cr

New Delhi: Ajanta Pharma on Wednesday reported 17.13 per cent decline in profit after tax (PAT)at Rs 94.49 crore for the quarter ended March 31, 2018 impacted by decline in…

  • Pharma
  • April 27, 2018
  • 185 views
Abbott discontinues selling Xience Alpine stents in India

New Delhi, Apr 26 : Healthcare firm Abbott today said it has fulfilled all the requirements to discontinue its Xience Alpine drug-eluting stent in India and will not be selling…

  • Pharma
  • April 21, 2018
  • 181 views
Novartis appoints John Tsai as Head of Global Drug Development and CMO

Basel, April 19, 2018 – Novartis announced today the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join Novartis…

  • Pharma
  • April 20, 2018
  • 216 views
P&G to acquire 52% in Merck India for Rs 1,300cr

MUMBAI: Global consumer products major, The Procter & Gamble Company (P&G), will acquire a nearly 52% stake in drug firm Merck India for Rs 1,300 crore as part of a…

  • Pharma
  • April 18, 2018
  • 295 views
NITI Aayog backs cap on pharma trade margins

New Delhi: Trade margins charged by drug stockists and chemists must be capped, government think tank NITI Aayog recommended, a move that promises to bring down drug prices while trimming…